Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly sales reps offered voluntary exit

US drugmaker Eli Lilly has offered buyouts to thousands of its US sales representatives

US drugmaker Eli Lilly has offered buyouts to thousands of its US sales representatives in the hope that several hundred will opt for voluntary redundancy ahead of a planned restructuring.

Approximately 4,000 sales employees in the US diabetes, neuroscience and osteoporosis units will be eligible for the programme, but buyouts are limited to a few hundred.

"We're trying to lower our headcount ahead of the restructuring and get us closer to the desired number" said company spokesman Edward Sagebiel.

Employees who accept the buyout will be offered the company's standard severance package plus an additional four months pay, Sagebiel said.

The new structure will feature smaller territories, each with one sales rep who has deep expertise in a treatment area. The plans are to be announced in November 2009 and will begin in January 2010.

Eli Lilly have acknowledged that the headcount reductions are a response to the challenging economic environment and the 2011 patent expiration of its top-selling Zyprexa (olanzapine) schizophrenia drug.

5th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics